Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: A cross-sectional study of 1137 subjects

Hormone and Metabolic Research

Volumn 42, Issue 4, 2010, Pages 274-279

  Lewis, J G ^a   Borowski, K K ^a   Shand, B I ^b   George, P M ^a   Scott, R S ^b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

CBG; Cortisol; Free cortisol; Glucose; Insulin; Insulin resistance; Metabolic syndrome; Plasma; SHBG

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; SEX HORMONE BINDING GLOBULIN; TRANSCORTIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL;

AMBULATORY CARE FACILITIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; LIPID METABOLISM DISORDERS; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC; TRANSCORTIN;

EID: 77950463120     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1243260     Document Type: Article

References (44)

1. Katsuki A, Sumida Y, Murashima S, Fujii M, Ito K, Tsuchihashi K, Murata K, Yano Y, Shima T. Acute and chronic regulation of serum sex hormone-binding globulin levels by male noninsulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab 1996 81 2515-2519
2. Muller M, Grobbee DE, Tonkelaar den I, Lamberts SWJ, Schouw van der YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005 90 2618-2623 (Pubitemid 40686299)
3. Lewis JG, Shand BI, Elder PA, Scott RS. Plasma sex hormone-binding globulin rather than corticosteroid-binding globulin is a marker of insulin resistance in obese adult males. Diabet Obes Metab 2004 6 259-283
4. Tchernof A, Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 2000 32 526-536
5. Laaksonen DE, Niskanen L, Punnonen K, Nyyssnen K, Tuomainen T-P, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003 149 601-608
6. Reed MJ, Cheng RW, Simmonds M, Richmond W, James VH. Dietary lipids: an additional regulator of plasma levels of sex hormone-binding globulin. J Clin Endocrinol Metab 1987 64 1083-1085
7. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988 67 460-464
8. Maggio M, Lauretani F, Basaria S, Ceda GP, Bandinelli S, Metter EJ, Bos AJ, Rugiero C, Ceresini G, Paolisso G, Artoni A, Valenti G, Guralnik JM, Ferrucci L. Sex hormone-binding globulin levels across the adult lifespan in women: the role of body mass index and fasting insulin. J Endocrinol Invest 2008 31 597-601
9. Jayagopal V, Kilpatrick ES, Jennings PE, Holding S, Hepburn DA, Atkin SL. The biological variation of sex hormone-binding globulin in Type 2 diabetes. Diabetes Care 2004 27 278-280
10. McElduff A, Hitchman, R, McElduff P. Is sex hormone-binding globulin associated with glucose tolerance? Diabetic Medicine 2005 23 306-312
11. Haffner SM, Katz MS, Stern MP, Dunn JF. Relationship of sex hormone-binding globulin to overall adiposity and body fat distribution in a biethnic population. Int J Obes 1989 13 1-9
12. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M. Differential effects of insulin and insulin-like growth factor 1 on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J Clin Endocrinol Metab 1995 80 1283-1289
13. Fernndez-Real J-M, Pugeat M, Emptoz-Bonneton A, Ricart W. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid-binding globulin in lean, obese, and obese subjects with glucose intolerance. Metabolism 2001 50 1248-1252
14. Fernndez-Real J-M, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J, Ricart W. Serum corticosteroid-binding globulin concentration and Insulin Resistance Syndrome: A population study. J Clin Endocrinol Metab 2002 87 4680-4690
15. Lewis JG, Mpert B, Shand BI, Doogue MP, Soule SG, Frampton CM, Elder PA. Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Horm Metab Res 2006 38 241-245
16. Lewis JG, Shand BI, Frampton CM, Elder PA, Scott RS. Plasma levels of sex hormone-binding globulin, corticosteroid-binding globulin and cortisol in overweight subjects who develop impaired fasting glucose: a 3-year prospective study. Horm Metab Res 2009 41 255-259
17. Lewis JG, Longley NJ, Elder PA. Monoclonal antibodies to human sex hormone-binding globulin (SHBG): Characterization and use in a simple enzyme-linked immunosorbent assay (ELISA) of SHBG in plasma. Steroids 1999 64 259-265
18. Lewis JG, Lewis MG, Elder PA. An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. Clin Chim Acta 2003 328 121-128
19. Lewis JG, Manley L, Whitlow JC, Elder PA. Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma. Steroids 1992 57 82-85
20. Coolens J-L, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987 26 197-202
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15 539-553
23. Executive summary of the third report of the national Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 2486-2497
24. Muller M, den Tonkelaar I, Thijssen JHH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003 149 583-589 (Pubitemid 38054704)
25. Weinberg ME, Manson JE, Buring JE, Cook NR, Seely, EW, Ridker PM, Rexrode KM. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metab Clin Exp 2006 55 1473-1480
26. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993 77 56-60
27. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex-hormone-binding globulin gene. J Clin Invest 2007 117 3979-3987
28. Hautanen A. Synthesis and regulation of sex hormone-binding globulin in obesity. Int J Obes Relat Metab Disord 2000 24 S64-S70
29. Chubb SAP, Hyde Z, Almeida OP, Flicker L, Norman PE, Jamrozik K, Hankey GJ, Yeap BB. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower testosterone in older men: the Health in Men Study. Eur J Endocrinol 2008 158 785-792
30. Bataille V, Perret B, Evans A, Amouyel P, Arveiler D, Ducimetire P, Bard J-M, Ferrires J. Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis 2005 179 369-373
31. Laaksonen DE, Niskanen L, Punnonen K, Nyyssnen K, Tuomainen T-P, Valkonen V-P, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004 27 1036-1041
32. Pasquali R, Vicennati V. Steroids and the metabolic syndrome. J Steroid Biochem Mol Biol 2008 109 258-265
33. Fernndez-Real J-M, Pugeat M, Lpez-Bermejo A, Bornet H, Ricart W. Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women. Metab Clin Exper 2005 54 584-589
34. Araki T, Emoto M, Konishi T, Ikuno Y, Lee E, Teramura M, Motoyama K, Yokoyama H, Mori K, Koyama H, Shoji T, Nishizawa Y. Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus. Metab Clin Exper 2009 58 143-148
35. Schulze MB, Rimm EB, Shai IS, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004 27 1680-1687
36. Reynolds RM, Walker BR. Can cortisol predict the future in obesity? Clin Endocrinol 2007 67 1-2
37. Holt HB, Wild SH, Postle AD, Zhang J, Koster G, Umpleby M, Shojaee-Moradie F, Dewbury K, Wood PJ, Phillips DI, Byrne CD. Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men. Diabetologia 2007 50 1024-1032
38. Wang M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab 2005 2 3-16
39. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007 157 545-559
40. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003 67 25-32
41. Santini SA, Carrozza C, Lulli P, Zuppi C, Tonolo GC, Musumeci S. Atorvastatin treatment does not affect gonal or adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia. J Artheroscler Thromb 2003 10 160-164
42. Hacihanefioglu B, Somunkiran A, Mahmutoglu I, Sercelik A, Toptani S, Kervancioglu E. Effect of hypertension therapy with the angiotensin-converting enzyme inihibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome. Fertil Steril 2002 77 526-528
43. Gambineri A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin Endocrinol 2004 60 241-249
44. Stroud LR, Solomon C, Shenassa E, Papandonatos G, Niaura R, Lipsitt LP, LeWinn K, Buka SL. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: Still valid after all these years. Psychoneuroendocrinol 2007 32 140-150